Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Effexor XR in Depression
NCT00225524Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of venlafaxine in major depressive disorder (MDD), sponsored by Pfizer. Started Sep 2004; status: completed.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00225524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00225524.